MedPath
HSA Approval

MACGEL TABLET

SIN08119P

MACGEL TABLET

MACGEL TABLET

April 11, 1995

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

ALUMINIUM HYDROXIDE (DRIED GEL)

200 mg

Aluminum hydroxide

MAGNESIUM HYDROXIDE

200 mg

Magnesium hydroxide

DIMETHYLPOLYSILOXANE

25 mg

Dimethicone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MACGEL TABLET - HSA Approval | MedPath